Form 8-K - Current report:
SEC Accession No. 0001193125-25-329488
Filing Date
2025-12-23
Accepted
2025-12-23 07:08:26
Documents
12
Period of Report
2025-12-23
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ivvd-20251223.htm   iXBRL 8-K 58000
2 EX-99.1 ivvd-ex99_1.htm EX-99.1 22324
3 GRAPHIC img59752938_0.jpg GRAPHIC 85687
  Complete submission text file 0001193125-25-329488.txt   319262

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT ivvd-20251223.xsd EX-101.SCH 31866
14 EXTRACTED XBRL INSTANCE DOCUMENT ivvd-20251223_htm.xml XML 4691
Mailing Address 209 CHURCH STREET NEW HAVEN CT 06510
Business Address 209 CHURCH STREET NEW HAVEN CT 06510 (781) 819-0080
Invivyd, Inc. (Filer) CIK: 0001832038 (see all company filings)

EIN.: 851403134 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40703 | Film No.: 251594686
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)